Comprehensive transcriptional analysis using TCGA Research Network indicates that IDH mutation and 1p/19q combined deletion (IDHmut/1p19qcodel) gliomas reveal more favorable outcomes with a median overall survival (OS) of approximate 10 years. This evidence concerns the gene IDH1 and central nervous system cancer.